147 related articles for article (PubMed ID: 158454)
1. Experimental and clinical megakaryocytopoiesis.
Ebbe S
Clin Haematol; 1979 Jun; 8(2):371-94. PubMed ID: 158454
[No Abstract] [Full Text] [Related]
2. Thrombopoietin: in vitro predictions, in vivo realities.
Kaushansky K
Am J Hematol; 1996 Nov; 53(3):188-91. PubMed ID: 8895690
[No Abstract] [Full Text] [Related]
3. Erythropoiesis in culture.
Eaves AC; Eaves CJ
Clin Haematol; 1984 Jun; 13(2):371-91. PubMed ID: 6432390
[No Abstract] [Full Text] [Related]
4. [Heparin enhances the stimulating effect of thrombopoietin on megakaryocytopoiesis].
Chen Q; Shen Z; Han Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):462-4. PubMed ID: 11721408
[TBL] [Abstract][Full Text] [Related]
5. [Normal and pathologic granulopoiesis. A review [].
Góngora-Biachi RA; Hurtado-Monroy R; López-Karpovich X; González-Llaven J
Rev Invest Clin; 1982; 34(2):187-96. PubMed ID: 6750735
[No Abstract] [Full Text] [Related]
6. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
Kharchenko MF
Vopr Med Khim; 1973; 19(6):613-7. PubMed ID: 4277844
[No Abstract] [Full Text] [Related]
7. [Quantitative studies of megakaryokinetics in chronic myeloproliferative disorders].
Nagasawa T; Nakazawa M
Nihon Ketsueki Gakkai Zasshi; 1988 May; 51(3):617-23. PubMed ID: 3166570
[No Abstract] [Full Text] [Related]
8. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
9. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
10. Hematopoietic stem cells (third of three parts).
Quesenberry P; Levitt L
N Engl J Med; 1979 Oct; 301(16):868-72. PubMed ID: 384249
[No Abstract] [Full Text] [Related]
11. The spectrum of myeloproliferative disorders.
Gilbert HS
Med Clin North Am; 1973 Mar; 57(2):355-93. PubMed ID: 4570933
[No Abstract] [Full Text] [Related]
12. Human megakaryocytopoiesis.
Gewirtz AM
Semin Hematol; 1986 Jan; 23(1):27-42. PubMed ID: 3511535
[No Abstract] [Full Text] [Related]
13. [Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].
Petrov MN; Vashkinel' VK
Probl Gematol Pereliv Krovi; 1977 May; 22(5):18-23. PubMed ID: 267283
[No Abstract] [Full Text] [Related]
14. Studies on the phagocytic activity of neutrophilic leukocytes.
Brandt L
Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
[No Abstract] [Full Text] [Related]
15. Regulation of human megakaryocytopoiesis.
Han ZC; Bellucci S; Caen JP
Nouv Rev Fr Hematol (1978); 1990; 32(6):395-6. PubMed ID: 2101871
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin stimulation of megakaryocytopoiesis in agar culture.
Kellar KL; Rolovic Z; Evatt BL; Sewell ET; Ramsey RB
Prog Clin Biol Res; 1986; 215():209-13. PubMed ID: 3725778
[No Abstract] [Full Text] [Related]
17. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
18. The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells.
Berthier R; Prandini MH; Schweitzer A; Thevenon D; Martin-Sisteron H; Uzan G
Exp Hematol; 1997 Jun; 25(6):481-90. PubMed ID: 9197325
[TBL] [Abstract][Full Text] [Related]
19. Platelets in the myeloproliferative syndrome.
Weinfeld A; Branehög I; Kutti J
Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
[No Abstract] [Full Text] [Related]
20. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis.
Eaton DL; de Sauvage FJ
Exp Hematol; 1997 Jan; 25(1):1-7. PubMed ID: 8989900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
